{"doc_id": "si-2022-0415-reg-1", "parent_doc_id": "si-2022-0415", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "1. (1) These Regulations may be cited as the Medicinal Products (Control", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products (Control \n\nof Wholesale Distribution) (Amendment) Regulations 2022. \n\n(2) The Principal Regulations, \n\nthe Medicinal Products (Control of \nWholesale Distribution) Regulations 2007 (Amendment) Regulations 2009 \n(S.I. No. 2 of 2009), the Medicinal Products (Control of Wholesale \nDistribution) Regulations 2007 (Amendment) Regulations 2010 (S.I. No. 286 \nof 2010), the Medicinal Products (Control of Wholesale Distribution) \n(Amendment) Regulations 2012 (S.I. No. 274 of 2012), the Medicinal Products \n(Control of Wholesale Distribution) (Amendment) Regulations 2013 (S.I. No. \n164 of 2013), Regulation 7 of the Medicinal Products (Safety Features On \nPackaging) Regulations 2019 (S.I. No. 36 of 2019), the Medicinal Products \n(Control of Wholesale Distribution) (Amendment) Regulations 2019 (S.I. No. \n217 of 2019), the Medicinal Products (Control of Wholesale Distribution) \n(Amendment) Regulations 2021 (S.I. No. 1 of 2021) and these Regulations \nmay be cited together as “the Medicinal Products (Control of Wholesale \nDistribution) (Amendment) Regulations 2007 to 2022”.", "text_norm": "1 (1) regulation may cited medicinal product (control wholesale distribution) (amendment) regulation 2022 (2) principal regulation medicinal product (control wholesale distribution) regulation 2007 (amendment) regulation 2009 (s.i no 2 2009) medicinal product (control wholesale distribution) regulation 2007 (amendment) regulation 2010 (s.i no 286 2010) medicinal product (control wholesale distribution) (amendment) regulation 2012 (s.i no 274 2012) medicinal product (control wholesale distribution) (amendment) regulation 2013 (s.i no 164 2013) regulation 7 medicinal product (safety feature packaging) regulation 2019 (s.i no 36 2019) medicinal product (control wholesale distribution) (amendment) regulation 2019 (s.i no 217 2019) medicinal product (control wholesale distribution) (amendment) regulation 2021 (s.i no 1 2021) regulation may cited together medicinal product (control wholesale distribution) (amendment) regulation 2007 2022", "start_char": 745, "end_char": 1884, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-reg-2", "parent_doc_id": "si-2022-0415", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "2. These Regulations shall be deemed to have come into operation on 1", "text_raw": "2. These Regulations shall be deemed to have come into operation on 1 \n\nJanuary 2022.", "text_norm": "2 regulation shall deemed come operation 1 january 2022", "start_char": 1884, "end_char": 1972, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-reg-3", "parent_doc_id": "si-2022-0415", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "In these Regulations “Principal Regulations” means the Medicinal", "text_raw": "3. \n\nIn these Regulations “Principal Regulations” means the Medicinal \nProducts (Control of Wholesale Distribution) Regulations 2007 (S.I. No. 538 \nof 2007).", "text_norm": "3 regulation principal regulation mean medicinal product (control wholesale distribution) regulation 2007 (s.i no 538 2007)", "start_char": 1972, "end_char": 2132, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-reg-4", "parent_doc_id": "si-2022-0415", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "4. Regulation 4(1) of the Principal Regulations is amended by substituting", "text_raw": "4. Regulation 4(1) of the Principal Regulations is amended by substituting \n\nfor the definition of “2001 Directive” the following: \n“‘2001 Directive’ means Directive 2001/83/EC of the European Parliament and \nof the Council on the Community code relating to medicinal products for \nhuman use1 (as amended);”. \n\n1 OJ No. L. 118, 20.4.2022, p.4. \n1 OJ No. L. 311, 28.11.2001, p.67. \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 23rd August, 2022. \n\n \n \n \n \n \n \n \n \n \n \n\f[415] 3", "text_norm": "4 regulation 4(1) principal regulation amended substituting definition 2001 directive following 2001 directive mean directive 2001 83 ec european parliament council community code relating medicinal product human use1 (as amended)  1 oj no l 118 20.4.2022 p.4 1 oj no l 311 28.11.2001 p.67 notice making statutory instrument published iris oifigiuil 23rd august 2022 415 3", "start_char": 2132, "end_char": 2654, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-reg-5", "parent_doc_id": "si-2022-0415", "section_id": "reg-5", "section_label": "Regulation 5.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "5. The Principal Regulations are amended by inserting after Regulation 15", "text_raw": "5. The Principal Regulations are amended by inserting after Regulation 15 \n\nthe following: \n\n“16. (1) By 20 May 2022, the Board shall establish, notify to the Commission \nand publish on its website a list of medicinal products to which it has applied \nor intends to apply the derogations as set out in paragraph 24 of Schedule 2. \n\n(2) The Board shall ensure that the list referred to in paragraph (1) is \n\nupdated at least on a six-monthly basis. \n\n(3) Any marketing authorisation holder who intends to avail of the \nderogations set out in paragraph 24 of Schedule 2 shall notify the Board and \nensure that the relevant medicinal product is included on the list referred to in \nparagraph (1) before the relevant medicinal product is placed on the market in \nthe State. Wholesalers of medicinal products shall not apply those derogations \nwith respect to any medicinal product until the relevant medicinal product is \nincluded on the list referred to in paragraph (1).”", "text_norm": "5 principal regulation amended inserting regulation 15 following 16 (1) 20 may 2022 board shall establish notify commission publish website list medicinal product applied intends apply derogation set paragraph 24 schedule 2 (2) board shall ensure list referred paragraph (1) updated least six-monthly basis (3) marketing authorisation holder intends avail derogation set paragraph 24 schedule 2 shall notify board ensure relevant medicinal product included list referred paragraph (1) relevant medicinal product placed market state wholesaler medicinal product shall apply derogation respect medicinal product relevant medicinal product included list referred paragraph (1)", "start_char": 2654, "end_char": 3626, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-reg-6", "parent_doc_id": "si-2022-0415", "section_id": "reg-6", "section_label": "Regulation 6.", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "6. Schedule 2 of the Principal Regulations is hereby amended by inserting", "text_raw": "6. Schedule 2 of the Principal Regulations is hereby amended by inserting \n\nafter subparagraph 23 the following: \n\n“24. (1) Notwithstanding anything to the contrary in these Regulations – \n\n(a) until 31 December 2024, the Board shall allow the import of \nmedicinal products from parts of the United Kingdom other than \nNorthern Ireland by holders of a wholesaler’s authorisation that \nare not in possession of a relevant manufacturing authorisation \nfollowing submission of a request by the holders of the \nmarketing authorisation for the medicinal products provided that \nall of the following conditions are fulfilled – \n\n(i) \n\n(ii) \n\n(iii) \n\n(iv) \n\n(v) \n\nthe medicinal products have undergone quality control \ntesting either in the Union, as provided for in Article 51(3) \nof the 2001 Directive, or in parts of the United Kingdom \nother than Northern Ireland in compliance with Article 20, \nfirst paragraph, point (b) of the 2001 Directive, \n\nthe medicinal products have been subject to batch release \nby a qualified person in the Union in accordance with \nArticle 51(1) of the 2001 Directive, or in parts of the \nUnited Kingdom other than Northern Ireland applying \nquality standards that are equivalent to those laid down in \nArticle 51(1) of the 2001 Directive, \n\nthe marketing authorisation for the medicinal product \nconcerned has been granted in accordance with Union law, \nby the Board or by the Commission, \n\nthe medicinal products are only made available to patients \nor end-consumers in the State, and \n\nthe medicinal products bear the safety features referred to \nin Article 54, point (o) of the 2001 Directive. \n\n \n \n\f4 [415] \n\n(2) Notwithstanding anything to the contrary in these Regulations, until 31 \nDecember 2024, Article 80, first subparagraph, point (b) of the 2001 Directive \nshall not apply to imports that fulfil the conditions laid down in paragraph (1).” \n\nGIVEN under the Official Seal of the Minister for Health, \n\n18 August, 2022. \n\nMUIRIS O'CONNOR, \n\nA person authorised under section 15 of the Ministers and \nSecretaries Act 1924 to authenticate the seal of the \nMinister for Health. \n\n. \n\n \n \n \n \n \n \n \n \n \n \n\f[415] 5", "text_norm": "6 schedule 2 principal regulation hereby amended inserting subparagraph 23 following 24 (1) notwithstanding anything contrary regulation - (a) 31 december 2024 board shall allow import medicinal product part united kingdom northern ireland holder wholesaler authorisation possession relevant manufacturing authorisation following submission request holder marketing authorisation medicinal product provided following condition fulfilled - (i) (ii) (iii) (iv) (v) medicinal product undergone quality control testing either union provided article 51(3) 2001 directive part united kingdom northern ireland compliance article 20 first paragraph point (b) 2001 directive medicinal product subject batch release qualified person union accordance article 51(1) 2001 directive part united kingdom northern ireland applying quality standard equivalent laid article 51(1) 2001 directive marketing authorisation medicinal product concerned granted accordance union law board commission medicinal product made available patient end-consumers state medicinal product bear safety feature referred article 54 point (o) 2001 directive 4 415 (2) notwithstanding anything contrary regulation 31 december 2024 article 80 first subparagraph point (b) 2001 directive shall apply import fulfil condition laid paragraph (1) given official seal minister health 18 august 2022 muiris connor person authorised section 15 minister secretary act 1924 authenticate seal minister health  415 5", "start_char": 3626, "end_char": 5779, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
{"doc_id": "si-2022-0415-explanatory-note", "parent_doc_id": "si-2022-0415", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 415 of 2022", "title": "Provisions) Act 2006 (No. 3 of 2006)) of the Irish Medicines Board Act 1995", "year": 2022, "heading": "(This note is not part of the instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the instrument and does not purport to be a legal \ninterpretation) \n\nThe main purpose of these Regulations is to implement Articles 2(5) and 2(11) \nof Directive (EU) 2022/642 of the European Parliament and of the Council of \n12 April 2022, which amend Directive 2001/83/EC as regards derogations \nfrom certain obligations concerning certain medicinal products for human use. \n\n \n \n \n \n \n\f6 [415] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-437) 75. 8/22. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation) main purpose regulation implement article 2(5) 2(11) directive (eu) 2022 642 european parliament council 12 april 2022 amend directive 2001 83 ec regard derogation certain obligation concerning certain medicinal product human use 6 415 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 3.00 (dh-437) 75 8 22 propylon", "start_char": 5779, "end_char": 6705, "source_path": "downloads\\2022\\2022_0414.pdf", "extraction_method": "pdfminer", "checksum": "sha256:aacdb52d195e8e5075f0beef0bd8235afcdce41ffcf4eead77f9549ca370a944", "cross_refs": []}
